Hussain, Arif
Jiang, Shan
Varghese, Della
Appukkuttan, Sreevalsa
Kebede, Nehemiah
Gnanasakthy, Kajan
Macahilig, Cynthia
Waldeck, Reg
Corman, Shelby
Article History
Received: 27 September 2021
Accepted: 11 February 2022
First Online: 22 March 2022
Declarations
:
: This study adhered to the principles of the Declaration of Helsinki and was approved by the New England Institutional Review Board in October 2019, with an exemption from informed consent under 45 CFR 46116(f).
: Not applicable.
: Reg Waldeck and Sreevalsa Appukkuttan are employees of Bayer Healthcare Pharmaceuticals. Shan Jiang was an employee of Bayer Healthcare Pharmaceuticals at the time the study was conducted. Shelby Corman and Nehemiah Kebede were employees of OPEN Health, which was a paid consultancy for the study, at the time the study was conducted. Kajan Gnanasakthy is an employee of RTI Health Solutions, which was a paid consultancy for the study. Cynthia Macahilig was an employee of RTI Health Solutions at the time the study was conducted. Arif Hussain has served in a consulting or advisory role for Novartis, AstraZeneca, Bayer, and Bristol-Myers Squibb, and has received research funding from Sotio, Merck, Bayer, Agensys, Clovis Oncology, and Cerulean Pharma.